Keros Therapeutics
KROS· Manufacturing· Fiscal year ends in December
Jasbir Seehra, Ph.D. is the CEO of Keros Therapeutics and was paid $2.5M in FY2025 (Dec), down 60%.
Executives4
See all- 1Christopher RovaldiFormer President and Chief Operating OfficerFY2024
- 2Jasbir Seehra, Ph.D.President and Chief Executive OfficerFY2025
- 3Keith RegnanteChief Financial OfficerFY2025
- 4Esther Cho, Esq.Chief Legal OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allKeros Therapeutics paid its 3 named executives $4.8M in total in FY2025 (Dec). CEO Jasbir Seehra, Ph.D. was paid $2.5M of that.
| Name | |||
|---|---|---|---|
| Jasbir Seehra, Ph.D.President and Chief Executive Officer | |||
| Keith RegnanteChief Financial Officer | |||
| Esther Cho, Esq.Chief Legal Officer | Not disclosed | Not disclosed | |
| Christopher RovaldiFormer President and Chief Operating Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe FY2025 (Dec) proxy of Keros Therapeutics names 19 peer companies for pay. Among Keros Therapeutics and these peers, CEO pay was the lowest of 8 and total shareholder return was 7th highest of 8.
8th highest of 8in Keros Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
7th highest of 8in Keros Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Jean-Jacques BienaiméLead independent director · 0 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
- Carl L. GordonDirector · 4 yr on the boardIndependentCompensation—Paid as an executive
- Nima FarzanDirector · 4 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
- Tomer KarivDirector · 4 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 22, 2026 | FY2025 |
| Annual report | 10-K | Mar 4, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 23, 2025 | FY2024 |
| Annual report | 10-K | Feb 26, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 17, 2024 | FY2023 |
| Annual report | 10-K | Feb 28, 2024 | FY2023 |